Elutia ELUT
NASDAQ ELUT
$0.84 +0.04 (+5.30%)
As of: Sep 10, 2026 · 12:14 PM EDT

Elutia (ELUT) Income from Discontinued Operations (2022 - 2026)

Elutia's (ELUT) quarterly Income from Discontinued Operations came in at $425000.0 in Q1 2026, up 120.77% year-over-year from $192506.1 in Q1 2025, and down 99.45% quarter-over-quarter from $77.3 million in Q4 2025.

Analysis

Elutia (ELUT) Income from Discontinued Operations (2022 - 2026) Analysis & Trends

Elutia has disclosed Income from Discontinued Operations across 5 years of filings, most recently posting $425000.0 for Q1 2026.

  • In Q1 2026, Income from Discontinued Operations rose 120.77% year-over-year to $425000.0; the TTM figure through Jun 2026 stood at $74.2 million (up 970.96% YoY), while the FY2025 annual figure was $69.3 million, up 904.87% from the prior year.
  • Income from Discontinued Operations came in at $425000.0 for Q1 2026 at Elutia, down from $77.3 million in the prior quarter.
  • In the past five years, Income from Discontinued Operations ranged from a high of $77.3 million in Q4 2025 to a low of -$3.5 million in Q3 2025.
  • Average Income from Discontinued Operations over 5 years is $5.1 million, with a median of -$524000.0 recorded in 2023.
  • The largest YoY upside for Income from Discontinued Operations was 4155.67% in 2025 against a maximum downside of 1499.44% in 2025.
  • Over 5 years, Income from Discontinued Operations stood at $575000.0 in 2022, then surged by 927.48% to $5.9 million in 2023, then slumped by 132.26% to -$1.9 million in 2024, then jumped by 4155.67% to $77.3 million in 2025, then slumped by 99.45% to $425000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Discontinued Operations figures were $425000.0 in Q1 2026, $77.3 million in Q4 2025, and -$3.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 181.23 Bn 175.63 Bn 7.27 Bn -
2 Intuitive Surgical 127.53 Bn 122.31 Bn 1.96 Bn -
3 Medtronic 117.08 Bn 108.26 Bn 6.34 Bn -
4 Stryker 105.08 Bn 101.60 Bn 4.50 Bn -
5 Boston Scientific 64.51 Bn 63.97 Bn 3.85 Bn -
6 Edwards Lifesciences 49.91 Bn 45.66 Bn 1.35 Bn -
7 Alcon 33.07 Bn 31.61 Bn 1.68 Bn -
8 Dexcom 32.35 Bn 30.40 Bn 830.00 Mn -
9 Steris 20.78 Bn 20.30 Bn 684.20 Mn -
10 Elutia 37.26 Mn 17.36 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 425,000.00
Dec 31, 2025 77.30 Mn
Sep 30, 2025 -3.49 Mn
Jun 30, 2025 -2.52 Mn
Mar 31, 2025 -2.05 Mn
Dec 31, 2024 -1.91 Mn
Sep 30, 2024 -2.05 Mn
Jun 30, 2024 180,000.00
Dec 31, 2023 5.91 Mn
Sep 30, 2023 -1.23 Mn
Jun 30, 2023 -2.89 Mn
Mar 31, 2023 1.81 Mn
Dec 31, 2022 575,000.00
Sep 30, 2022 1.12 Mn